Innovus Pharmaceuticals Inc. (fka INNV)

[Biotech Pharmer]

"Although Innovus is actively working to put the drug on the shelf of retail stores, its best advantage and most lucrative way to sell FlutiCare™ is through the company's robust Beyond Human® sales and marketing platform and strong online presence."

Their distribution focus is through Beyond Human. Good luck with that doc. And starting a sentence with "although" is never good. And selling at $13.50,assuming that's the 120 spray-sized bottle, is in line with Walmart's Equate. It doesn't state of that $13.50 is for 60 spray or 120 spray. If it's 120, that is positive for revs, but not margins. If it's 60 spray, they'll have a hard time selling any.